Synthesis of 1,4-dihydropyridine derivatives with vasodilating activities (I)
Original Articles
Received:
- 41 Downloads
Abstract
□Asymmetric 2,6-dimethyl-4-aryl-1,4-dihydropyridine-3,5-dicarboxylate with [N-(3,4-methylenedioxybenzyl)-N-methyl] aminoethyl group as the ester moiety and related 1,4-dihydropyridine derivatives were prepared and tested for the effects on vascular smooth muscles. 2,6-dimethyl-4-(3′-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[N-(3′, 4′-methylenedioxybenzyl)-N-methyl] aminoethyl ester 5-methyl ester (11) and 2,6-dimethyl-4-(3′-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[N-2′,3′-methylenedioxybenzyl)-N-methyl] aminoethyl ester 5-ethyl ester (15) showed potent vasodilating activities. IC50 (10−8 M) was 2.6 and 2.7 for11 and15, compared with 3.5 for nicardipine.
Keywords
□1,4-Dihydropyridines vasodilating activities nicardipinePreview
Unable to display preview. Download preview PDF.
Literature Cited
- 1.Grün Von G. and Fleckenstein, A.: Die elektromechanische Entkoppelung der glatten Gefa β muskulatur als Grundprinzip der Coronardilatation durch 4-(2′-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonsäure dimethylester (BAY a 1040, Nifedipine).Arzneim.—Forsch. (Drug Res.),22, 334 (1972).Google Scholar
- 2.Bossert, F. and Vater, W.: Dihydropyridine, eine neu Gruppe stark wisksamer Coronartherapeutika.Naturwissenschaften,58, 578 (1979).CrossRefGoogle Scholar
- 3.Meyer Von H., Bossert F., Wehinger, E., Stoepel, K. and Vater W.: Synthese und Vergleichende Pharmakologische Untersuchungen von 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3, 5-dicarbonsäureestern mit nicht-identischen Ester-funktionen.Arzeneim.—Foresch. (Drug Res.),31, 407 (1981).Google Scholar
- 4.Bossert F., Meyer H. and Wehinger, E.: 4-Aryldihydropyridines, a New Class of Highly Active Calcium Antagonists.Angew. Chem. Int. Ed. Eng.,20, 762 (1981).CrossRefGoogle Scholar
- 5.Prous, J., Blancafort, P., Castaner, J., Serradell, M.N. and Mealy N.: Biologically Active 1,4-Dihydropyridine Derivatives.Drugs of the Future,6, 427 (1981).Google Scholar
- 6.Janis, R.A. and Triggle, D.J.: New Developments in Ca2+ Channel Antagonists.J. Med. Chem. 26, 775 (1983).PubMedCrossRefGoogle Scholar
- 7.Iwanami, M., Shibanuma, T., Fujimoto, M., Kawai, R., Tamazawa, K., Takenaka, T., Takahashi, K. and Murakami, M.: Synthesis of New Water-Soluble Dihydropyridine Vasodilators.Chem. Pharm. Bull. 27, 1426 (1979).PubMedGoogle Scholar
- 8.Ohno, S., Komatsu, O., Mizukoshi, K., Ichihara, K.: Synthesis of Asymmetric 4-Aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with Vasodilating and Antihypertensive Activities.Chem. Pharm. Bull. 34, 1589 (1986).PubMedGoogle Scholar
- 9.Suh, J.J. and Hong, Y.H.: Synthesis of 1,4-Dihydropyridine Carboxylic Acids.Yakhak Hoeji,33, 80 (1989).Google Scholar
- 10.Suh, J.J. and Hong, Y.H.: Synthesis of 1,4-Dihydropyridine Carboxylic Acids (II).Yakhak Hoeji,33, 219 (1989).Google Scholar
- 11.Muto, K., Kuroda, T., Karasawa, A., Yamada, K. and Nakamizo, N.: 1,4-Dihydropyridine derivatives.European patent Application,106, 275 (1983).Google Scholar
- 12.Hof, R.P. and Vuorela, H.J.: Assessing Calcium Antagonism on Vascular Smooth Muscle: A Comparison of Three Methods.J. Pharmacol. Methods,9, 41 (1983).PubMedCrossRefGoogle Scholar
Copyright information
© The Pharmaceutical Society of Korea 1990